Assessment of the Ocular Microbiome in Health and Disease
NCT05414994 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-01-22
Summary
The objective of this application is to illustrate the core constituents of the ocular surface microbiome, describe factors that promote colonization, and assess the ocular microbiome's role in the health of the anterior segment. We will conduct a prospective, observational cohort study, including a longitudinal analysis of the ocular microbiome in adults.
Conditions
- Microbial Colonization
- Eye Diseases
- Ophthalmopathy
Interventions
- OTHER
-
Eye swab
This is a simple swab under the eyelids of both eyes
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-07
- Primary Completion
- 2027-09-30
- Completion
- 2027-12-30
Countries
- United States
Study Locations
More Related Trials
-
Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults
NCT03382405 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002432 ·Status: COMPLETED ·Phase: NA
-
Ganciclovir Implant Study for Cytomegalovirus Retinitis
NCT00000118 ·Status: COMPLETED ·Phase: PHASE3
-
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
NCT00006145 ·Status: COMPLETED ·Phase: PHASE3
-
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
NCT00017784 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis
NCT00004794 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
CMV Infection in Adolescent Males
NCT00302029 ·Status: TERMINATED
-
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002377 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
NCT06494033 ·Status: RECRUITING
-
Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis
NCT01359995 ·Status: UNKNOWN
-
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002330 ·Status: COMPLETED ·Phase: NA
-
Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients
NCT04654325 ·Status: TERMINATED ·Phase: NA
-
A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine
NCT04975893 ·Status: COMPLETED ·Phase: PHASE2
-
De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients
NCT06001320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis
NCT01486693 ·Status: UNKNOWN
-
High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients
NCT03598452 ·Status: COMPLETED ·Phase: NA
-
Cytomegalovirus Control in Critical Care
NCT01503918 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002384 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
NCT02594566 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS
NCT00002034 ·Status: COMPLETED ·Phase: NA
-
Breakthrough CMV Lung Transplant -Multicentre
NCT04439916 ·Status: RECRUITING
-
Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
NCT00677482 ·Status: COMPLETED
-
Cytomegalovirus Vaccine in Healthy Participants
NCT00712634 ·Status: COMPLETED ·Phase: PHASE1